Contraceptive efficacy of a novel spermicidal microbicide used with a diaphragm: A randomized controlled trial

Obstetrics and Gynecology

Volumn 110, Issue 3, 2007, Pages 577-586

  Barnhart, Kurt T ^a   Rosenberg, Michael J ^b   MacKay, H Trent ^b   Blithe, Diana L ^b   Higgins, Jim ^b   Walsh, Terri ^b   Wan, Livia ^b   Thomas, Michael ^b   Creinin, Mitchell D ^b   Westhoff, Carolyn ^b   Schlaff, William ^b   Archer, David F ^b   Ayers, Charletta ^b   Kaunitz, Andrew ^b   Das, Sutapa ^b   Moench, Thomas R ^b  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACID BUFFERING AGENT; BUFFER; NONOXINOL 9; SPERMICIDAL AGENT; UNCLASSIFIED DRUG; CARBOPOL 974P; CONTRACEPTIVE AGENT;

ADULT; ARTICLE; BACTERIURIA; BREAKTHROUGH BLEEDING; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTRACEPTION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAPHRAGM; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; GEL; GENITAL PRURITUS; HUMAN; INFLUENZA; MENSTRUAL IRREGULARITY; MULTICENTER STUDY; NORMAL HUMAN; PREGNANCY OUTCOME; PREGNANCY RATE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHINOPHARYNGITIS; TREATMENT DURATION; URINARY TRACT INFECTION; VAGINA DISCHARGE; VAGINA IRRITATION; VAGINA PAIN; VAGINITIS; ABSCESS; ACIDITY; BACTERIAL INFECTION; BACTERIAL VAGINOSIS; COMPARATIVE STUDY; CONFERENCE PAPER; CONTRACEPTIVE BEHAVIOR; FEMALE GENITAL TRACT PARAMETERS; GYNECOLOGICAL EXAMINATION; METRORRHAGIA; OUTCOME ASSESSMENT; SEXUALLY TRANSMITTED DISEASE; SOCIAL ACCEPTANCE; UPPER RESPIRATORY TRACT INFECTION; UTERINE CERVIX CAP; VAGINA DISEASE; VAGINA MYCOSIS; VAGINAL ACIDITY; VAGINAL IRRITATION;

ADOLESCENT; ADULT; ANTI-INFECTIVE AGENTS; CONTRACEPTIVE DEVICES, FEMALE; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYDROGEN-ION CONCENTRATION; NONOXYNOL; PATIENT SATISFACTION; PREGNANCY; PREGNANCY RATE; SAFETY; SEXUALLY TRANSMITTED DISEASES; SPERMATOCIDAL AGENTS; TREATMENT OUTCOME; VAGINAL CREAMS, FOAMS, AND JELLIES;

EID: 34548389667     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.AOG.0000278078.45640.13     Document Type: Article

References (32)

1. Dhawan D, Mayer KH. Microbicides to prevent HIV transmission: overcoming obstacles to chemical barrier protection. J Infect Dis 2006;193:36-44.
2. Hillier SL, Moench T, Shattock R, Black R, Reichelderfer P, Veronese F. In vitro and in vivo: the story of nonoxynol 9. J Acquir Immune Defic Syndr 2005;39:1-8.
3. Hicks DR, Martin LS, Getchell JP, Heath JL, Francis DP, McDougal JS, et al. Inactivation of HTLV-III/LAV-infected cultures of normal human lymphocytes by nonoxynol-9 in vitro. Lancet 1985;2:1422-3.
4. Roddy RE, Cordero M, Cordero C, Fortney JA. A dosing study of nonoxynol-9 and genital irritation. Int J STD AIDS 1993;4:165-70.
5. Wilkinson D, Tholandi M, Ramjee G, Rutherford GW. Nonoxynol-9 spermicide for prevention of vaginally acquired HIV and other sexually transmitted infections: systematic review and meta-analysis of randomised controlled trials including more than 5000 women. Lancet Infect Dis 2002;2:613-7.
6. Kreiss J, Ngugi E, Holmes K, Ndinya-Achola J, Waiyaki P, Roberts PL, et al. Efficacy of nonoxynol 9 contraceptive sponge use in preventing heterosexual acquisition of HIV in Nairobi prostitutes. JAMA 1992;268:477-82.
7. Van Damme L, Ramjee G, Alary M, Vuylsteke B, Chandeying V, Rees H, et al; COL-1492 Study Group. Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomised controlled trial [published erratum appears in Lancet 2002;360:1892]. Lancet 2002;360:971-7.
8. WHO/CONRAD technical consultation on nonoxynol-9, World Health Organization, Geneva, 9-10 October 2001: summary report. Reprod Health Matters 2002;10:175-81.
9. Olmsted SS, Dubin NH, Cone RA, Moench TR. The rate at which human sperm are immobilized and killed by mild acidity. Fertil Steril 2000;73:687-93.
10. Hillier S, Holmes KK. Normal vaginal flora. In: Holmes KK, Sparling PF, Mardh PA, Lemon SM, Stamm WE, Piot P, Wasserheit JN, editors. Sexually transmitted diseases. 3rd ed. New York (NY): McGraw-Hill; 1999. p 193-4.
11. Boskey ER, Telsch KM, Whaley KJ, Moench TR, Cone RA. Acid production by vaginal flora in vitro is consistent with the rate and extent of vaginal acidification. Infect Immun 1999;67:5170-5.
12. Masters WH, Johnson VE. Human sexual response. Boston (MA): Little, Brown; 1966.
13. Zeitlin L, Hoen TE, Achilles SL, Hegarty TA, Jerse AE, Kreider JW, et al. Tests of BufferGel for contraception and prevention of sexually transmitted diseases in animal models. Sex Transm Dis 2001;28:417-23.
14. Olmsted SS, Khanna KV, Ng EM, Whitten ST, Johnson ON 3rd, Markham RB, et al. Low pH immobilizes and kills human leukocytes and prevents transmission of cell-associated HIV in a mouse model. BMC Infect Dis 2005;5:79.
15. Ongradi J, Ceccherini-Nelli L, Pistello M, Specter S, Bendinelli M. Acid sensitivity of cell-free and cell-associated HIV-1: clinical implications. AIDS Res Hum Retroviruses 1990;6: 1433-6.
16. Mauck C, Callahan M, Weiner DH, Dominik R. A comparative study of the safety and efficacy of FemCap, a new vaginal barrier contraceptive, and the Ortho All-Flex diaphragm. The FemCap Investigators' Group. Contraception 1999;60:71-80.
17. CONRAD/World Health Organization. Manual for the standardization of colposcopy for the evaluation of vaginal products. CONRAD, 2004. Available at: http://www.who.int/reproductive-health/stis/colposcopy.html. Retrieved June 12, 2007.
18. Blackwelder W. "Proving the null hypothesis" in clinical trials. Control Clin Trials 1982;3:345-53.
19. Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV, et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer 1977;35:1-39.
20. Trussell J. Contraceptive failure in the United States. Contraception 2004;70:89-96.
21. Raymond EG, Chen PL, Luoto J. Contraceptive effectiveness and safety of five nonoxynol-9 spermicides: a randomized trial. Obstet Gynecol 2004;103:430-9.
22. Steiner MJ, Dominik R, Rountree RW, Nanda K, Dorflinger LJ. Contraceptive effectiveness of a polyurethane condom and a latex condom: a randomized controlled trial [published erratum appears in Obstet Gynecol 2003;101:1026]. Obstet Gynecol 2003;101:539-47.
23. Trussell J, Vaughan B. Contraceptive failure, method-related discontinuation and resumption of use: results from the 1995 National Survey of Family Growth. Fam Plann Perspect 1999;31:64-72.
24. Hooton TM, Roberts PL, Stamm WE. Effects of recent sexual activity and use of a diaphragm on the vaginal microflora. Clin Infect Dis 1994;19:274-8
25. Raymond E, Chen PL, Bosny P, Luoto J, Barnhart KT, Bradley L, et al. Participant characteristics associated with withdrawal from a large randomized trial of spermicide effectiveness. BMC Med Res Methodol 2004;4:23.
26. Mayer KH, Peipert J, Fleming T, Fullem A, Moench T, Cu-Uvin S, et al. Safety and tolerability of BufferGel, a novel vaginal microbicide, in women in the United States. Clin Infect Dis 2001;32:476-82.
27. van De Wijgert J, Fullem A, Kelly C, Mehendale S, Rugpao S, Kumwenda N, et al. Phase 1 trial of the topical microbicide BufferGel: safety results from four international sites. J Acquir Immune Defic Syndr 2001;26:21-7.
28. Fu H, Darroch JE, Hass T, Ranjit N. Contraceptive failure rates: new estimates from the 1995 National Survey of Family Growth. Fam Plann Perspect 1999;31:56-63.
29. Moench TR, Chipato T, Padian NS. Preventing disease by protecting the cervix: the unexplored promise of internal vaginal barrier devices. AIDS 2001;15:1595-602.
30. Kunz G, Beil D, Deininger H, Wildt L, Leyendecker G. The dynamics of rapid sperm transport through the female genital tract: evidence from vaginal sonography of uterine peristalsis and hysterosalpingoscintigraphy. Hum Reprod 1996;11:627-32.
31. Barnhart KT, Stolpen A, Pretorius ES, Malamud D. Distribution of a spermicide containing nonoxynol-9 in the vaginal canal and the upper female reproductive tract. Hum Reprod 2001;16:1151-4.
32. Spencer SE, Valentin-Bon IE, Whaley K, Jerse AE. Inhibition of Neisseria gonorrhoeae genital tract infection by leading-candidate topical microbicides in a mouse model. J Infect Dis 2004;189:410-9.